|
CY2018004I2
(el)
|
|
Συνδυαστικη θεραπεια υποκατεστημενης oξαζολιδινονης
|
|
DK3424932T3
(da)
|
|
Bronophthalider til terapeutisk anvendelse
|
|
DK2041139T3
(da)
|
|
Farmaceutiske forbindelser
|
|
ATE443753T1
(de)
|
|
Nuancierungsmittel
|
|
DK1986650T3
(da)
|
|
Manipulationssikre doserignsformer
|
|
DK2035369T3
(da)
|
|
Terapeutiske
|
|
DK2144905T3
(da)
|
|
Terapeutiske midler
|
|
FR2896407B3
(fr)
|
|
Ambulateur
|
|
BRPI0916931A2
(pt)
|
|
agentes terapêuticos
|
|
FI20065069A
(fi)
|
|
Liitinmekanismi
|
|
DK2073795T3
(da)
|
|
Misbrugssikret lægemiddelformulation
|
|
DE602007012130D1
(de)
|
|
Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
|
|
ATE524477T1
(de)
|
|
Aziridinylepothilonverbindungen
|
|
DK2094292T3
(da)
|
|
Salpeteroxid-blokeret tværbundet tetramerisk hæmoglobin
|
|
AT504580A3
(de)
|
|
Scan-einrichtung
|
|
DK2178568T3
(da)
|
|
Kontrastmidler
|
|
ATE546437T1
(de)
|
|
Aminomethyl-4-imidazole
|
|
DE502007000218D1
(de)
|
|
nsetzungen
|
|
DE502007002453D1
(de)
|
|
Kunstoffverdichtergehäuse
|
|
DE502006006067D1
(de)
|
|
Ng
|
|
DE602006020744D1
(de)
|
|
Fertigspritze
|
|
ATE534010T1
(de)
|
|
Zielfernrohr
|
|
DE502007000361D1
(de)
|
|
Stanznieteinheit
|
|
DE502007001629D1
(de)
|
|
Rfahren
|
|
BRPI0820410A2
(pt)
|
|
Lactans substituídos terapêuticos
|